Form D · Biotechnology
Cubed Biotech Inc.
Dollard Des Ormeaux, A8 · CIK 0002046652
Offering snapshot reported Jan 15, 2025 · SEC filing
- Reported sold
- $500K Offering amount: $1M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Dec 31, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 15, 2025 | Initial | $500,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $85K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-535285
(1) Cash payment equal to 10% of gross proceeds, (2) warrant for 107,419 shares of issuer's common stock, and (3) placement agent's legal fees.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Joseph Gunnar & Co., LLC | 24795 |
Source: Form D, filed Jan 15, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Adam B. Coape Arnold | Director, Executive, Promoter |
| Douglas H. Coape Arnold | Director |
| Dave Farris | Executive, Promoter |
| Anthony Rossi | Director, Executive, Promoter |
| Jonathan Soosaipillai | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
275 Kesmark Street
Dollard Des Ormeaux, A8, H9B 3J1
Dollard Des Ormeaux, A8, H9B 3J1